Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


5 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Qual Outcomes
2 Circ Genom Precis Med
1 Eur Heart J
3 Heart
5 Int J Cardiol
1 J Am Coll Cardiol
1 J Cardiovasc Pharmacol
4 J Electrocardiol
1 J Interv Card Electrophysiol
2 Pacing Clin Electrophysiol
4 PLoS One
1 Stroke

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Circ Arrhythm Electrophysiol

  1. MCCAULEY MD, Darbar D
    Race and Socioeconomic Status Regulate Lifetime Risk of Atrial Fibrillation.
    Circ Arrhythm Electrophysiol. 2018;11:e006584.
    PubMed     Text format    

    Letter by Schuster Regarding Article, "Outcomes and Management of Patients With Severe Pulmonary Vein Stenosis From Prior Atrial Fibrillation Ablation".
    Circ Arrhythm Electrophysiol. 2018;11:e006581.
    PubMed     Text format    

  3. STEINBERG JS, O'Connell H, Li S, Ziegler PD, et al
    Thirty-Second Gold Standard Definition of Atrial Fibrillation and Its Relationship With Subsequent Arrhythmia Patterns: Analysis of a Large Prospective Device Database.
    Circ Arrhythm Electrophysiol. 2018;11:e006274.
    PubMed     Text format     Abstract available

  4. MOU L, Norby FL, Chen LY, O'Neal WT, et al
    Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities).
    Circ Arrhythm Electrophysiol. 2018;11:e006350.
    PubMed     Text format     Abstract available

  5. TERRICABRAS M, Verma A, Morillo CA
    Measuring Success in Ablation of Atrial Fibrillation: Time for a Paradigm Shift?
    Circ Arrhythm Electrophysiol. 2018;11:e006582.
    PubMed     Text format    

    Circ Cardiovasc Qual Outcomes

  6. ABDEL-QADIR H, Fang J, Lee DS, Tu JV, et al
    Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004580.
    PubMed     Text format     Abstract available

    Circ Genom Precis Med

  7. HAGGERTY CM, Murray B, Tichnell C, Judge DP, et al
    Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical Surveillance.
    Circ Genom Precis Med. 2018;11:e002237.
    PubMed     Text format    

  8. NAKANO Y, Ochi H, Sairaku A, Onohara Y, et al
    HCN4 Gene Polymorphisms Are Associated With Occurrence of Tachycardia-Induced Cardiomyopathy in Patients With Atrial Fibrillation.
    Circ Genom Precis Med. 2018;11:e001980.
    PubMed     Text format     Abstract available

    Eur Heart J

  9. COWAN JC, Wu J, Hall M, Orlowski A, et al
    A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
    Eur Heart J. 2018 Jul 5. pii: 5049393. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. OTTO CM
    Heartbeat: Causes and consequences of atrial fibrillation.
    Heart. 2018;104:1229-1231.
    PubMed     Text format    

  11. SANDHU RK, Ezekowitz JA
    Is incentivising stroke prevention therapy in atrial fibrillation the key?
    Heart. 2018 Jul 10. pii: heartjnl-2018-313402. doi: 10.1136/heartjnl-2018-313402
    PubMed     Text format    

  12. ADDERLEY NJ, Ryan R, Nirantharakumar K, Marshall T, et al
    Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.
    Heart. 2018 Jul 10. pii: heartjnl-2018-312977. doi: 10.1136/heartjnl-2018-312977
    PubMed     Text format     Abstract available

    Int J Cardiol

  13. WENG CJ, Li CH, Liao YC, Lin CC, et al
    Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort study.
    Int J Cardiol. 2018 Jun 26. pii: S0167-5273(18)33463.
    PubMed     Text format     Abstract available

    Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation.
    Int J Cardiol. 2018 Jul 2. pii: S0167-5273(18)33478.
    PubMed     Text format    

  15. KHEIRI B, Osman M, Abdalla A, Haykal T, et al
    Catheter ablation of atrial fibrillation with heart failure: An updated meta-analysis of randomized trials.
    Int J Cardiol. 2018 Jul 4. pii: S0167-5273(18)32169.
    PubMed     Text format     Abstract available

  16. BORIANI G, Proietti M, Laroche C, Diemberger I, et al
    Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot gener
    Int J Cardiol. 2018 Jul 9. pii: S0167-5273(17)38059.
    PubMed     Text format     Abstract available

  17. BEIERT T, Knappe V, Tiyerili V, Stockigt F, et al
    Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.
    Int J Cardiol. 2018;250:21-28.
    PubMed     Text format     Abstract available

    J Am Coll Cardiol

    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed     Text format    

    J Cardiovasc Pharmacol

  19. JANION-SADOWSKA A, Papuga-Szela E, Lukaszuk R, Chrapek M, et al
    Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000607.
    PubMed     Text format     Abstract available

    J Electrocardiol

  20. BANAVALIKAR B, Shenthar J
    Electrocardiographic characteristics and mapping approach of ventricular arrhythmias originating from the left ventricular summit.
    J Electrocardiol. 2018;51:687-690.
    PubMed     Text format     Abstract available

  21. CHENITI G, Takigawa M, Vlachos K, Thompson N, et al
    Double loop reentrant atrial tachycardia following ablation for atrioventricular nodal reentrant tachycardia.
    J Electrocardiol. 2018;51:677-679.
    PubMed     Text format     Abstract available

  22. PRZYZYCKA P, Kalowski M, Poddebska I, Kaczmarek K, et al
    Self-terminating ventricular fibrillation recorded by an implantable loop recorder as a cause of syncope - A case report.
    J Electrocardiol. 2018;51:617-619.
    PubMed     Text format     Abstract available

  23. YAMAGUCHI Y, Mizumaki K, Sakamoto T, Nakatani Y, et al
    Citrus fruits induced swallow syncope with atrioventricular block or sinus arrest.
    J Electrocardiol. 2018;51:613-616.
    PubMed     Text format     Abstract available

    J Interv Card Electrophysiol

  24. SAKSENA S, Slee A, Saad M
    Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    J Interv Card Electrophysiol. 2018 Jul 9. pii: 10.1007/s10840-018-0408.
    PubMed     Text format     Abstract available

    Pacing Clin Electrophysiol

  25. VAKSMANN G, Klug D
    Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Pacing Clin Electrophysiol. 2018 Jul 10. doi: 10.1111/pace.13446.
    PubMed     Text format     Abstract available

  26. DE ASMUNDIS C, Chierchia GB, La Meir M
    Extracardiac ice formation during CoolLoop cryo ablation of atrial fibrillation.
    Pacing Clin Electrophysiol. 2018 Jul 10. doi: 10.1111/pace.13440.
    PubMed     Text format     Abstract available

    PLoS One

  27. KULKARNI K, Xie X, Fernandez de Velasco EM, Anderson A, et al
    The influences of the M2R-GIRK4-RGS6 dependent parasympathetic pathway on electrophysiological properties of the mouse heart.
    PLoS One. 2018;13:e0193798.
    PubMed     Text format     Abstract available

  28. MCHORNEY CA, Crivera C, Laliberte F, Germain G, et al
    Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users.
    PLoS One. 2018;13:e0194099.
    PubMed     Text format     Abstract available

  29. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    PubMed     Text format     Abstract available

  30. SETHI NJ, Nielsen EE, Safi S, Feinberg J, et al
    Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    PLoS One. 2018;13:e0193924.
    PubMed     Text format     Abstract available


  31. LAMSAM L, Sussman ES, Iyer AK, Bhambhvani HP, et al
    Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation: Direct Oral Anticoagulants Versus Warfarin.
    Stroke. 2018 Jul 10. pii: STROKEAHA.118.022156.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.